Key Takeaways
- • Real Diagnostics, backed by HCAP Partners, has acquired SimplyTest, a saliva-based oral health testing company.
- • SimplyTest's PERIO test uses a swish-and-spit saliva sample to identify periodontal pathogens.
- • The deal expands Real Diagnostics' portfolio into oral health diagnostics, according to PE Hub.
Summary
Real Diagnostics, a diagnostics platform backed by HCAP Partners, has added SimplyTest, a saliva-based oral health testing firm, according to a PE Hub brief. The acquisition extends Real Diagnostics' offering into oral health testing.
SimplyTest's flagship PERIO test relies on a swish-and-spit saliva sample to identify periodontal pathogens, the bacteria associated with gum disease. The non-invasive collection method is the core of the company's product proposition.
The source article is a brief and does not disclose the transaction value, financial terms, or the seller. Further detail on deal economics and strategic rationale was not available in the reporting reviewed.
SimplyTest's flagship PERIO test relies on a swish-and-spit saliva sample to identify periodontal pathogens, the bacteria associated with gum disease. The non-invasive collection method is the core of the company's product proposition.
The source article is a brief and does not disclose the transaction value, financial terms, or the seller. Further detail on deal economics and strategic rationale was not available in the reporting reviewed.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.